Treatment of H4IIE rat hepatoma and Hep3B human hepatoma cells with curcumin (2–50 μM) resulted in significantly reduced dexamethasone-induced PEPCK and G6Pase activity, indicating reduced gluconeogenesis (Table 2) [73]. Here, PCK2 is linked to hepatocellular carcinoma.